G38
If you find any inaccurate information, please let us know by providing your feedback here
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
Phase G1 containing a small percentage of a tailing inhibitor.
[NOTE-A suitable grade is available commercially as "SP2100/0.1% Carbowax 1500" from Supelco, Inc. (www.sigmaaldrich.com/supelco).]
